MAMohamad Anas Abou-Shamat

Mohamad Anas Abou-Shamat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohamad Anas Abou-Shamat has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Design-of-Experiments approach to developing thermoresponsive gelators from complex polymer mixtures

    by Mohamad Anas Abou-Shamat, Jacqueline Leslie Stair, Stewart B. Kirton, Jesus Calvo-Castro, Michael T. Cook

    This study investigated the effects of additives on the properties of poloxamer (P) 407 thermogels, employing a Design-of-Experiments (DoE) approach.


  • Modifying the Properties of Thermogelling Poloxamer 407 Solutions through Covalent Modification and the Use of Polymer Additives

    by Mohamad A. Abou‐Shamat, Jesus Calvo‐Castro, Jacqueline L. Stair, Michael T. Cook

    Thermoresponsive polymers that undergo sol–gel transition in a physiological temperature range have applications in biomedical science. Poloxamer 407 (P407) is commonly used as thermogelling material and has been approved by the Food and Drug Administration (FDA) in licenced medicines. However, it has significant drawbacks which limit its performance, particularly in drug delivery systems. In order to improve these properties, the chemical structure of P407 has been modified to produce stronger gels by either conjugating P407 with other polymers or introducing inter‐micelle linkers to the terminal hydroxyl groups of P407. However, chemical modifications have several undesirable side‐effects. The change in the chemical structure makes the polymer a novel excipient, and additional safety risks are possible, requiring expensive and time‐consuming toxicity testing prior to regulatory approval. An alternative approach to covalent modification is modifying the P407 formulations with additives including hydrophilic polymers and nanoparticles, in an attempt to improve the properties of these materials. This review investigates the approaches used to modify the properties of P407 thermogelling materials, including the use of polymer additives and covalent modification. Several recommendations are made, based on efficacy and consideration of regulatory risk to guide the development of these materials toward use in real clinical applications.


  • Soluplus solutions as thermothickening materials for topical drug delivery

    by I. Salah, M. Abou Shamat, M. T. Cook

    Soluplus is a pharmaceutical excipient used primarily in the manufacture of solid dispersions. The polymer also exhibits interesting rheology in aqueous solution, increasing in viscosity as the solution is warmed. This material could have application topical drug delivery to sites including the skin, vagina, rectum or nasal mucosa, where the increase in viscosity allows for improved retention. However, there exists very little information surrounding this “thermothickening” phenomenon and the effect of solution composition on temperature‐dependent rheology. In this study, the effect of soluplus concentration, salt inclusion, ethanol addition, and pH on temperature‐dependent rheology was measured. The rheology of the solutions was unaffected by pH over the range tolerated by the skin (pH 4–7), but the inclusion of ethanol rapidly negated the thermothickening effect. “Salting out” of the solutions resulted in a depression of gelation temperatures, and an increase in both storage and loss moduli of the solutions. 30% (w/v) soluplus in 1 M NaCl or KCl was identified as a potential thermothickening agent for topical drug delivery. © 2018 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2019, 136, 46915.